Cardiac effects of antimalarial treatment with halofantrine.
In a prospective electrocardiographic study of Karen patients with acute uncomplicated falciparum malaria, mefloquine (25 mg/kg) had no cardiac effects (n = 53), but halofantrine (72 mg/kg) induced consistent dose-related lengthening of the PR and QT intervals in all 61 patients treated. The likelih...
Príomhchruthaitheoirí: | Nosten, F, ter Kuile, F, Luxemburger, C, Woodrow, C, Kyle, D, Chongsuphajaisiddhi, T, White, N |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
1993
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria.
de réir: ter Kuile, F, et al.
Foilsithe / Cruthaithe: (1993) -
Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.
de réir: Nosten, F, et al.
Foilsithe / Cruthaithe: (1994) -
Other 4-methanolquinolines, amyl alcohols and phentathrenes: Mefloquine, lumefantrine and halofantrine
de réir: Nosten, F, et al.
Foilsithe / Cruthaithe: (2012) -
Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria.
de réir: Krishna, S, et al.
Foilsithe / Cruthaithe: (1993) -
Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography.
de réir: Ter Kuile, F, et al.
Foilsithe / Cruthaithe: (1994)